Literature DB >> 20422835

[The utility of a continuous performance test embedded in virtual reality in measuring the effectiveness of MPH treatment in boys with ADHD].

Liron Shriki1, Merav Weizer, Yehuda Pollak, Patricia L Weiss, Albert A Rizzo, Varda Gross-Tsur.   

Abstract

BACKGROUND: Continuous performance tasks (CPT) are popular in the diagnostic process of attention deficit hyperactivity disorder (ADHD), providing an objective measure of attention for a disorder with otherwise subjective criteria. AIMS: The study aimed to: 1) examine whether the VR-CPT is sensitive to methylphenidate (MPH); 2) assess how the virtual reality (VR) environment is experienced.
METHODS: Twenty boys, 9-17 years, with ADHD underwent 3 CPTs: VR-CPT, the same CPT without VR (no VR-CPT) and the Test of Variables of Attention (T.O.V.A.). Subsequently, those with ADHD repeated the tests 1 hour following MPH ingestion. Immediately following the CPT, the subjects described their subjective experiences on the Short Feedback Questionnaire. Results were analyzed using ANOVA with repeated measures.
RESULTS: MPH reduced the omission and commission errors on all tests to a similar degree. Subjective feelings of enjoyment were most positive for VR-CPT.
CONCLUSION: The VR-CPT is a sensitive and user-friendly assessment tool for evaluating the effectiveness of MPH treatment in boys with ADHD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20422835

Source DB:  PubMed          Journal:  Harefuah        ISSN: 0017-7768


  2 in total

Review 1.  The usefulness of virtual, augmented, and mixed reality technologies in the diagnosis and treatment of attention deficit hyperactivity disorder in children: an overview of relevant studies.

Authors:  Saeideh Goharinejad; Samira Goharinejad; Sadrieh Hajesmaeel-Gohari; Kambiz Bahaadinbeigy
Journal:  BMC Psychiatry       Date:  2022-01-04       Impact factor: 3.630

2.  Design process and preliminary psychometric study of a video game to detect cognitive impairment in senior adults.

Authors:  Sonia Valladares-Rodriguez; Roberto Perez-Rodriguez; David Facal; Manuel J Fernandez-Iglesias; Luis Anido-Rifon; Marcos Mouriño-Garcia
Journal:  PeerJ       Date:  2017-06-30       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.